Market Place
Sourcing Support
Syngene International Reports Q2 FY25 PAT at Rs. 106.1 Cr
25 Oct 2024 //
INDPHARMAPOST
Syngene Secures Silver Rating In EcoVadis Sustainability Index
13 Aug 2024 //
PRESS RELEASE
Syngene reports drop in Q1 FY25 revenue to Rs. 790 Cr
25 Jul 2024 //
INDIANPHARMAPOST
Syngene reports first quarter results
24 Jul 2024 //
PRESS RELEASE
Syngene launches platform for rapid, enhanced protein production
05 Jun 2024 //
PHARMABIZ
Syngene launches platform for rapid, enhanced protein production
04 Jun 2024 //
PR NEWSWIRE
Syngene International reports Q4 FY24 consolidated PAT at Rs. 188.6 Cr
24 Apr 2024 //
INDINPHARMAPOST
Goldman Sach initiates `buy` on Syngene, Neuland, adds `sell` tag to Larus Lab
11 Apr 2024 //
MONEYCONTROL
Syngene facility to be operational for US, European customers from mid-year
17 Mar 2024 //
INDIAN PHARMA POST
Syngene biologics manufacturing facility to be operational for US from mid-year
14 Mar 2024 //
PR NEWSWIRE
Syngene Q3 FY 24 PAT up 4% to Rs 115 Cr
26 Jan 2024 //
INDIAN PHARMA POST
Stelis Biopharma updates on receipt of consideration from Syngene
25 Dec 2023 //
INDIAN PHARMA POST
Syngene concludes acquisition of biologics manufacturing facility from Stelis
03 Dec 2023 //
INDIAN PHARMA POST
Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr
18 Oct 2023 //
INDIAN PHARMA POST
Strides sells arm`s manufacturing unit to Syngene International for Rs 702 crore
05 Jul 2023 //
ECONOMIC TIMES
Syngene International sees strong momentum this fiscal year: MD
08 May 2023 //
ECONOMICTIMES
Syngene International Gets Zero Observations from US FDA for Biologics Facility
15 Nov 2022 //
MARKETSCREENER
Syngene reports Rs 102 crore net profit in Q2FY23
19 Oct 2022 //
ECONOMIC TIMES
Syngene set for phase-2 trial of Covid oral tablet vaccine
12 Oct 2022 //
ECONOMIC TIMES
Syngene set for phase-2 trial of Covid oral tablet vaccine
11 Oct 2022 //
ECONOMIC TIMES
Syngene International slips after muted Q1 performance
19 Jul 2022 //
BUSINESS-STANDARD
Biocon arm Syngene ends contract with Bioinnovat Research over graft case
05 Jul 2022 //
BUSINESS-STANDARD
Syngene releases ESG report for FY20-21
24 Feb 2022 //
PHARMABIZ
Syngene International announces extension of collaboration with Amgen
17 Dec 2021 //
EXPRESSPHARMA
Syngene, Amgen Extend R&D Collaboration
16 Dec 2021 //
CONTRACTPHARMA
Syngene gets extension of collaboration with Amgen contract until 2026
16 Dec 2021 //
PHARMABIZ
Syngene revenue up by 17% , PAT increases to 9%
21 Oct 2021 //
PHARMABIZ
Syngene Expands Biopharma Manufacturing Capacity
17 Aug 2021 //
CONTRACT PHARMA
Syngene expands biopharma-manufacturing capacity with microbial facility
11 Aug 2021 //
PHARMABIZ
Syngene appoints two senior leaders in US
04 Aug 2021 //
EXPRESS PHARMA
Sygene to Extend its Research Collaboration with Bristol Myers Squibb
11 May 2021 //
PHARMTECH
Syngene, BMS Extend Long Term Research Alliance until 2030
30 Apr 2021 //
CONTRACTPHARMA
Syngene targets delivering 500,000 vials of remdesivir in India as COVID-19
28 Apr 2021 //
REUTERS
Syngene and 3DC Sign 5-year Collaboration
24 Nov 2020 //
CONTRACTPHARMA
Anthem Bio catches global buyout funds` eye, stake sale could see valuation rocket to $1 billion
25 Sep 2020 //
ECONOMIC TIMES
Syngene International rallies 13% in two days; stock nears record high
23 Jul 2020 //
BUSINESS-STANDARD
Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits
02 Jun 2020 //
EXPRESSPHARMA
JB Chemicals & Pharma, Syngene International hit all-time highs
21 May 2020 //
BUSINESS-STANDARD
Syngene commissions phase-1 of new R&D centre in Hyderabad
17 Feb 2020 //
MONEYCONTROL
Artelo, Syngene, Aptus enter into global R&D partnership
12 Jun 2018 //
BIOSPECTRUM
Artelo Enters Into Global R&D Partnership With Syngene International
12 Jun 2018 //
PR NEWSWIRE
Syngene plans to scale up for biologics
04 Aug 2017 //
ECONOMIC TIMES
Syngene International slips over 4%
27 Apr 2017 //
INDIAINFOLINE
Syngene to develop nutrition products for Herbalife
02 Mar 2017 //
BUSINESS-STANDARD
Massive Fire in Biocon`s Syngene Complex in Bengaluru, No Casualties
13 Dec 2016 //
BUSINESS STANDARD
US FDA actions, DPCO hit sales & profits of top 30 cos in first half of 2016-17
21 Nov 2016 //
PHARMABIZ
Syngene International hits new high on sealing deal with Strand Life Science
21 Sep 2016 //
BUSSINESS-STANDARD
BioSpectrum Ranking Survey: Rank 5: Syngene International
16 Sep 2016 //
BIOSPECTRUM
Syngene International gains after starting new development center in Bangalore
06 Sep 2016 //
BUSINESS-STANDARD
Syngene lines up $200 million capex to boost manufacturing
22 Jul 2016 //
ECONOMIC TIMES
Syngene International net up by 17.5% in Q1
21 Jul 2016 //
PHARMABIZ
India`s Biocon takes a hit from analysts, but Mazumdar-Shaw upbeat
25 Jan 2016 //
FIERCE PHARMA ASIA
Syngene Q3 profit up 31%; revenue up 23%
21 Jan 2016 //
BIOSPECTRUM INDIA
India has `natural potential to grow` in CRO space, says Syngene CEO
14 Jan 2016 //
IN-PHARMATECHNOLOGIST
Up and down the ladder: The latest comings and goings
06 Jan 2016 //
STAT
Biocon arm Syngene names Jonathan Hunt as CEO-designate
04 Jan 2016 //
BUSINESS STANDARD
India`s Syngene aims to build $100M API, chemicals plant
11 Dec 2015 //
FIERCE PHARMA ASIA
Syngene Q2 net profits up 31% over previous year
20 Oct 2015 //
BIOSPECTRUM INDIA
Syngene to invest $100 mn for new plant in Mangalore SEZ
31 Aug 2015 //
THE ECONOMIC TIMES
USFDA observations not serious, says Biocon
21 Aug 2015 //
BUSINESS STANDARD
